drugset / Trial / NCT04245566

Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH

NCT04245566

Phase 3 Unknown 425 enrolled Dominik Abt
RandomizedParallel-groupOpen-labelTreatment

Summary

This study compares safety and efficacy of prostatic artery embolization and pharmacotherapy in the treatment of lower urinary tract symptoms associated wit benign prostatic hyperplasia.

Timeline

Start
2021-09
Primary completion
2022-12
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dutasteride Small molecule 0.5 mg
Comparator Tamsulosin Other / unclassified 0.4 mg